{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:45:13Z","timestamp":1792093513166,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL142086, R01DK118941, R01DK118805, and R01DK121548"],"award-info":[{"award-number":["R01HL142086, R01DK118941, R01DK118805, and R01DK121548"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-06915-x","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T19:01:53Z","timestamp":1728586913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH"],"prefix":"10.1038","volume":"7","author":[{"given":"Shuwei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathima N.","family":"Cassim Bawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Gopoju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1886-7775","authenticated-orcid":false,"given":"Yanqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"6915_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12997","volume":"48","author":"X Unamuno","year":"2018","unstructured":"Unamuno, X. et al. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur. J. Clin. Invest. 48, e12997 (2018).","journal-title":"Eur. J. Clin. Invest."},{"key":"6915_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00109-009-0520-x","volume":"87","author":"MR Thompson","year":"2009","unstructured":"Thompson, M. R., Xu, D. & Williams, B. R. ATF3 transcription factor and its emerging roles in immunity and cancer. J. Mol. Med. 87, 1053\u20131060 (2009).","journal-title":"J. Mol. Med."},{"key":"6915_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3727\/105221610X12819686555015","volume":"15","author":"T Hai","year":"2010","unstructured":"Hai, T., Wolford, C. C. & Chang, Y. S. ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component? Gene Expr. 15, 1\u201311 (2010).","journal-title":"Gene Expr."},{"key":"6915_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature04768","volume":"441","author":"M Gilchrist","year":"2006","unstructured":"Gilchrist, M. et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441, 173\u2013178 (2006).","journal-title":"Nature"},{"key":"6915_CR5","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.4049\/jimmunol.179.6.3622","volume":"179","author":"MM Whitmore","year":"2007","unstructured":"Whitmore, M. M. et al. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J. Immunol. 179, 3622\u20133630 (2007).","journal-title":"J. Immunol."},{"key":"6915_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.2784","volume":"15","author":"D De Nardo","year":"2014","unstructured":"De Nardo, D. et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat. Immunol. 15, 152\u2013160 (2014).","journal-title":"Nat. Immunol."},{"key":"6915_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s42255-020-00331-1","volume":"3","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism. Nat. Metab. 3, 59\u201374 (2021).","journal-title":"Nat. Metab."},{"key":"6915_CR8","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.2337\/db21-0181","volume":"70","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Hepatocytic activating transcription factor 3 protects against steatohepatitis via hepatocyte nuclear factor 4\u03b1. Diabetes 70, 2506\u20132517 (2021).","journal-title":"Diabetes"},{"key":"6915_CR9","doi-asserted-by":"crossref","unstructured":"Wang, X. et al. Recent advances in adipose tissue dysfunction and its role in the pathogenesis of non-alcoholic fatty liver disease. Cells 10, 3300 (2021).","DOI":"10.3390\/cells10123300"},{"key":"6915_CR10","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1172\/JCI129187","volume":"129","author":"CR Kahn","year":"2019","unstructured":"Kahn, C. R., Wang, G. & Lee, K. Y. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J. Clin. Invest. 129, 3990\u20134000 (2019).","journal-title":"J. Clin. Invest."},{"key":"6915_CR11","doi-asserted-by":"crossref","unstructured":"Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","DOI":"10.1097\/HEP.0000000000000520"},{"key":"6915_CR12","doi-asserted-by":"crossref","unstructured":"Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542\u20131556 (2023).","DOI":"10.1097\/HEP.0000000000000696"},{"key":"6915_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"6915_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang, D. Q., El-Serag, H. B. & Loomba, R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 18, 223\u2013238 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"6915_CR15","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3892\/ijmm.2015.2085","volume":"35","author":"J Yin","year":"2015","unstructured":"Yin, J. et al. Palmitate induces endoplasmic reticulum stress and autophagy in mature adipocytes: implications for apoptosis and inflammation. Int. J. Mol. Med. 35, 932\u2013940 (2015).","journal-title":"Int. J. Mol. Med."},{"key":"6915_CR16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"T Yamauchi","year":"2002","unstructured":"Yamauchi, T. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288\u20131295 (2002).","journal-title":"Nat. Med."},{"key":"6915_CR17","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1074\/jbc.M505311200","volume":"281","author":"AR Nawrocki","year":"2006","unstructured":"Nawrocki, A. R. et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281, 2654\u20132660 (2006).","journal-title":"J. Biol. Chem."},{"key":"6915_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ijms18061321","volume":"18","author":"AE Achari","year":"2017","unstructured":"Achari, A. E. & Jain, S. K. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int. J. Mol. Sci. 18, 1321 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"6915_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/MCO.0b013e328042ba90","volume":"10","author":"J Delarue","year":"2007","unstructured":"Delarue, J. & Magnan, C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 10, 142\u2013148 (2007).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"6915_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/en.2015-1866","volume":"157","author":"CG Wilson","year":"2016","unstructured":"Wilson, C. G. et al. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology 157, 570\u2013585 (2016).","journal-title":"Endocrinology"},{"key":"6915_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03003-w","volume":"11","author":"P Rada","year":"2020","unstructured":"Rada, P., Gonzalez-Rodriguez, A., Garcia-Monzon, C. & Valverde, A. M. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis. 11, 802 (2020).","journal-title":"Cell Death Dis."},{"key":"6915_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","volume":"8","author":"ZV Wang","year":"2016","unstructured":"Wang, Z. V. & Scherer, P. E. Adiponectin, the past two decades. J. Mol. Cell Biol. 8, 93\u2013100 (2016).","journal-title":"J. Mol. Cell Biol."},{"key":"6915_CR23","doi-asserted-by":"publisher","first-page":"E758","DOI":"10.1152\/ajpendo.00172.2018","volume":"315","author":"DB Harmon","year":"2018","unstructured":"Harmon, D. B. et al. Adipose tissue-derived free fatty acids initiate myeloid cell accumulation in mouse liver in states of lipid oversupply. Am. J. Physiol. Endocrinol. Metab. 315, E758\u2013E770 (2018).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"6915_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.biochi.2015.10.024","volume":"125","author":"P Morigny","year":"2016","unstructured":"Morigny, P., Houssier, M., Mouisel, E. & Langin, D. Adipocyte lipolysis and insulin resistance. Biochimie 125, 259\u2013266 (2016).","journal-title":"Biochimie"},{"key":"6915_CR25","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1210\/en.2015-1322","volume":"156","author":"G Schoiswohl","year":"2015","unstructured":"Schoiswohl, G. et al. Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated insulin resistance and inflammation in male mice. Endocrinology 156, 3610\u20133624 (2015).","journal-title":"Endocrinology"},{"key":"6915_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14859","volume":"8","author":"M Schweiger","year":"2017","unstructured":"Schweiger, M. et al. Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice. Nat. Commun. 8, 14859 (2017).","journal-title":"Nat. Commun."},{"key":"6915_CR27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1123965","volume":"312","author":"G Haemmerle","year":"2006","unstructured":"Haemmerle, G. et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312, 734\u2013737 (2006).","journal-title":"Science"},{"key":"6915_CR28","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bbalip.2018.10.008","volume":"1864","author":"R Schreiber","year":"2019","unstructured":"Schreiber, R., Xie, H. & Schweiger, M. Of mice and men: the physiological role of adipose triglyceride lipase (ATGL). Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864, 880\u2013899 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"6915_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112440","volume":"145","author":"HC Ku","year":"2022","unstructured":"Ku, H. C., Chan, T. Y., Chung, J. F., Kao, Y. H. & Cheng, C. F. The ATF3 inducer protects against diet-induced obesity via suppressing adipocyte adipogenesis and promoting lipolysis and browning. Biomed. Pharmacother. 145, 112440 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"6915_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s42003-019-0624-y","volume":"2","author":"CF Cheng","year":"2019","unstructured":"Cheng, C. F. et al. Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3. Commun. Biol. 2, 389 (2019).","journal-title":"Commun. Biol."},{"key":"6915_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep14470","volume":"5","author":"JW Kwon","year":"2015","unstructured":"Kwon, J. W. et al. Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-\u03baB. Sci. Rep. 5, 14470 (2015).","journal-title":"Sci. Rep."},{"key":"6915_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.livres.2017.08.001","volume":"1","author":"K Jadhav","year":"2017","unstructured":"Jadhav, K. & Zhang, Y. Activating transcription factor 3 in immune response and metabolic regulation. Liver Res. 1, 96\u2013102 (2017).","journal-title":"Liver Res."},{"key":"6915_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cmet.2009.01.006","volume":"9","author":"L Qi","year":"2009","unstructured":"Qi, L. et al. Adipocyte CREB promotes insulin resistance in obesity. Cell Metab. 9, 277\u2013286 (2009).","journal-title":"Cell Metab."},{"key":"6915_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jhep.2017.03.023","volume":"67","author":"JY Kim","year":"2017","unstructured":"Kim, J. Y. et al. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. J. Hepatol. 67, 349\u2013359 (2017).","journal-title":"J. Hepatol."},{"key":"6915_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0894-1","volume":"9","author":"Q Zhu","year":"2018","unstructured":"Zhu, Q. et al. Loss of ATF3 exacerbates liver damage through the activation of mTOR\/p70S6K\/ HIF-1\u03b1 signaling pathway in liver inflammatory injury. Cell Death Dis. 9, 910 (2018).","journal-title":"Cell Death Dis."},{"key":"6915_CR36","doi-asserted-by":"publisher","first-page":"21771","DOI":"10.1074\/jbc.M116.726364","volume":"291","author":"YF Liu","year":"2016","unstructured":"Liu, Y. F., Wei, J. Y., Shi, M. H., Jiang, H. & Zhou, J. Glucocorticoid induces hepatic steatosis by inhibiting activating transcription factor 3 (ATF3)\/S100A9 protein signaling in granulocytic myeloid-derived suppressor cells. J. Biol. Chem. 291, 21771\u201321785 (2016).","journal-title":"J. Biol. Chem."},{"key":"6915_CR37","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/hep.31604","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Hepatocyte nuclear factor 4\u03b1 prevents the steatosis-to-NASH progression by regulating p53 and bile acid signaling (in mice). Hepatology 73, 2251\u20132265 (2021).","journal-title":"Hepatology"},{"key":"6915_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1210\/me.2011-1157","volume":"26","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob\/ob mice. Mol. Endocrinol. 26, 272\u2013280 (2012).","journal-title":"Mol. Endocrinol."},{"key":"6915_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2018.06.019","volume":"28","author":"AI Mina","year":"2018","unstructured":"Mina, A. I. et al. CalR: a web-based analysis tool for indirect calorimetry experiments. Cell Metab. 28, 656\u2013666.e651 (2018).","journal-title":"Cell Metab."},{"key":"6915_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11010-008-9966-3","volume":"323","author":"ZX Shan","year":"2009","unstructured":"Shan, Z. X. et al. A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs. Mol. Cell Biochem. 323, 81\u201389 (2009).","journal-title":"Mol. Cell Biochem."},{"key":"6915_CR41","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ncb3328","volume":"18","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat. Cell Biol. 18, 431\u2013442 (2016).","journal-title":"Nat. Cell Biol."},{"key":"6915_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/oby.23929","volume":"32","author":"FN Cassim Bawa","year":"2024","unstructured":"Cassim Bawa, F. N. et al. Adipocyte retinoic acid receptor \u03b1 prevents obesity and steatohepatitis by regulating energy expenditure and lipogenesis. Obesity 32, 120\u2013130 (2024).","journal-title":"Obesity"},{"key":"6915_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101518","volume":"3","author":"D Roy","year":"2022","unstructured":"Roy, D., Myers, J. M. & Tedeschi, A. Protocol for assessing ex vivo lipolysis of murine adipose tissue. STAR Protoc. 3, 101518 (2022).","journal-title":"STAR Protoc."},{"key":"6915_CR44","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.celrep.2016.10.070","volume":"17","author":"C Sun","year":"2016","unstructured":"Sun, C. et al. Adipose Snail1 regulates lipolysis and lipid partitioning by suppressing adipose triacylglycerol lipase expression. Cell Rep. 17, 2015\u20132027 (2016).","journal-title":"Cell Rep."},{"key":"6915_CR45","doi-asserted-by":"publisher","first-page":"15054","DOI":"10.1074\/jbc.RA120.013322","volume":"295","author":"L Vergnes","year":"2020","unstructured":"Vergnes, L., Lin, J. Y., Davies, G. R., Church, C. D. & Reue, K. Induction of UCP1 and thermogenesis by a small molecule via AKAP1\/PKA modulation. J. Biol. Chem. 295, 15054\u201315069 (2020).","journal-title":"J. Biol. Chem."},{"key":"6915_CR46","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/ATVBAHA.119.312610","volume":"39","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Hepatic forkhead box protein A3 regulates ApoA-I (apolipoprotein A-I) expression, cholesterol efflux, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 39, 1574\u20131587 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"6915_CR47","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"key":"6915_CR48","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06915-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:08:11Z","timestamp":1732061291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06915-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6915"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06915-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1300"}}